Alnylam says Onpattro to be available from two specialty pharmacies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam rare drug gets FDA approval, to cost $345,000 on average
Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»
Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic
Alnylam (ALNY) receives FDA approval for Onpattro to treat polyneuropathy of hereditary transthy.....»»
Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow
Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow.....»»
Ionis CRL positive for Alnylam"s Onpattro, says B. Riley FBR
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
JMP says Pfizer data "impressive," but leave room for Alnylam"s Onpattro
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam receives approval of ONPATTRO in Europe
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam data publication points to positive Onpattro risk profile, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam announces submission of NDA in Japan for ONPATTRO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam launches ONPATTRO in Germany
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam"s Onpattro highly efficacious, safer than competitor, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A Sluggish Start With Onpattro Is Not What Alnylam Shareholders Needed
A Sluggish Start With Onpattro Is Not What Alnylam Shareholders Needed.....»»
Alnylam announces unaudited Q4 ONPATTRO revenues of $11M-$12M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam reports better-than-expected Onpattro revenues, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam (ALNY) Reports Preliminary Onpattro Revenues for Q4
Alnylam (ALNY) reports preliminary revenues for Onpattro for the fourth quarter of 2018, and also provides other update.....»»
Alnylam Reports Improved Onpattro Sales Going Into A Busy Year
Alnylam Reports Improved Onpattro Sales Going Into A Busy Year.....»»
Alnylam, Israel"s Medison partner to commercialize Onpattro, RNAi portfolio
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam & Medison Partner to Market RNAi Products in Israel
Alnylam (ALNY) partners with Israel's Medison Pharma to commercialize Onpattro and other RNAi pipeline candidates und.....»»
Walgreens to open cell and gene therapy pharmacy center in Pittsburgh
It's part of the growing market share of specialty drugs......»»
Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details
Walgreens Boots Alliance el.....»»